More Realistic Forecasting of Future Life Events After Psilocybin for Treatment-Resistant Depression

被引:37
作者
Lyons, Taylor [1 ]
Carhart-Harris, Robin Lester [1 ]
机构
[1] Imperial Coll London, Dept Med, Psychedel Res Grp, London, England
来源
FRONTIERS IN PSYCHOLOGY | 2018年 / 9卷
关键词
treatment-resistant depression; psilocybin; cognitive bias; pessimism; forecasting; LYSERGIC-ACID DIETHYLAMIDE; DEFAULT-MODE NETWORK; MYSTICAL-TYPE EXPERIENCES; 5-HT2A RECEPTOR-BINDING; DYSFUNCTIONAL ATTITUDES; SPIRITUAL SIGNIFICANCE; UNREALISTIC OPTIMISM; POSITIVE ILLUSIONS; THREATENING CANCER; HEALTHY-SUBJECTS;
D O I
10.3389/fpsyg.2018.01721
中图分类号
B84 [心理学];
学科分类号
04 ; 0402 ;
摘要
Background: Evidence suggests that classical psychedelics can promote enduring changes in personality, attitudes and optimism, as well as improvements in mental health outcomes. Aim: To investigate the effects of a composite intervention, involving psilocybin, on pessimism biases in patients with treatment-resistant depression (TRD). Methods: Patients with TRD (n = 15) and matched, untreated non-depressed controls (n = 15) performed the Prediction Of Future Life Events (POFLE) task. The POFLE task requires participants to predict the likelihood of certain life events occurring within a 30day period, after which the actual rate of event occurrence is reported; this gives an index of potential pessimism versus optimism bias. Psilocybin was administered in two oral dosing sessions (10 and 25 mg) one week apart. Main outcome measures were collected at baseline and one week after the second dosing session. Results: Patients showed a significant pessimism bias at baseline [t(14) = 3.260, p = 0.006; 95% CI (-0.16, -0.03), g = 1.1] which was related to the severity of their depressive symptoms (r(s) = 0.55, p = 0.017). One week after psilocybin treatment, this bias was significantly decreased [t(14) = 2.714, p = 0.017; 95% CI (-0.21, -0.02), g = 0.7] and depressive symptoms were greatly improved [t(14) = 7.900, p < 0.001; 95% CI (16.17, 28.23), g = 1.9]; moreover, the magnitude of change in both variables was significantly correlated (r = -0.57, p = 0.014). Importantly, post treatment, patients became significantly more accurate at predicting the occurrence of future life events [t(14) = 1.857, p = 0.042; 95% CI (-0.01, 0.12), g = 0.6] whereas no such change was observed in the control subjects. Conclusion: These findings suggest that psilocybin with psychological support might correct pessimism biases in TRD, enabling a more positive and accurate outlook.
引用
收藏
页数:11
相关论文
共 50 条
[31]   Defining treatment-resistant depression [J].
Gaynes, Bradley N. ;
Lux, Linda ;
Gartlehner, Gerald ;
Asher, Gary ;
Forman-Hoffman, Valerie ;
Green, Josh ;
Boland, Erin ;
Weber, Rachel P. ;
Randolph, Charli ;
Bann, Carla ;
Coker-Schwimmer, Emmanuel ;
Viswanathan, Meera ;
Lohr, Kathleen N. .
DEPRESSION AND ANXIETY, 2020, 37 (02) :134-145
[32]   Treatment-resistant depression - an update [J].
Kaschka, WP ;
Jandl, M .
NERVENHEILKUNDE, 2005, 24 (04) :317-+
[33]   Intranasal esketamine: From origins to future implications in treatment-resistant depression [J].
Sanders, Benjamin ;
Brula, Abdul Q. .
JOURNAL OF PSYCHIATRIC RESEARCH, 2021, 137 :29-35
[34]   Therapeutic Strategies for Treatment-resistant Depression: State of the Art and Future Perspectives [J].
Goh, Kah K. ;
Chang, Shen-Chieh ;
Chen, Chun-Hsin ;
Lu, Mong-Liang .
CURRENT PHARMACEUTICAL DESIGN, 2020, 26 (02) :244-252
[35]   Deep Brain Stimulation for Treatment-Resistant Depression: Towards a More Personalized Treatment Approach [J].
Roet, Milaine ;
Boonstra, Jackson ;
Sahin, Erdi ;
Mulders, Anne E. P. ;
Leentjens, Albert F. G. ;
Jahanshahi, Ali .
JOURNAL OF CLINICAL MEDICINE, 2020, 9 (09) :1-19
[36]   Quality of life across domains among individuals with treatment-resistant depression [J].
Lex, Heidemarie ;
Ginsburg, Yarden ;
Sitzmann, Adam F. ;
Grayhack, Clara ;
Maixner, Daniel F. ;
Mickey, Brian J. .
JOURNAL OF AFFECTIVE DISORDERS, 2019, 243 :401-407
[37]   Medication options in the treatment of treatment-resistant depression [J].
Pridmore, S ;
Turnier-Shea, Y .
AUSTRALIAN AND NEW ZEALAND JOURNAL OF PSYCHIATRY, 2004, 38 (04) :219-225
[38]   Preclinical models of treatment-resistant depression: challenges and perspectives [J].
Kolasa, Magdalena ;
Faron-Gorecka, Agata .
PHARMACOLOGICAL REPORTS, 2023, 75 (06) :1326-1340
[39]   Thalamocortical Dysconnectivity in Treatment-Resistant Depression [J].
Tu, Pei-Chi ;
Lin, Wei-Chen ;
Chang, Wan-Chen ;
Su, Tung-Ping ;
Li, Cheng-Ta ;
Bai, Ya-Mei ;
Tsai, Shih-Jen ;
Chen, Mu-Hong .
JOURNAL OF NEUROSCIENCE RESEARCH, 2024, 102 (10)
[40]   Preclinical models of treatment-resistant depression: challenges and perspectives [J].
Magdalena Kolasa ;
Agata Faron-Górecka .
Pharmacological Reports, 2023, 75 :1326-1340